| 2019-nCoV | novel coronavirus 2019 |
| ACE | angiotensin-converting enzyme |
| ACE2 | angiotensin-converting enzyme 2 |
| ADMA | asymmetric dimethylarginine |
| ADP | adenosine diphosphate |
| ALA | alpha-lipoic acid |
| AMI | acute myocardial infarction |
| Ang | angiotensin |
| Ang 1-7 | angiotensin 1 to 7 |
| ARDS | acute respiratory distress syndrome |
| ARE | antioxidant response element |
| AT1 | angiotensin II type 1 receptor |
| ATP | adenosine triphosphate |
| BH4 | tetrahydrobiopterin |
| BPRS | Brief Psychiatric Rating Scale |
| CIS | cytokine-inducible Src homology 2 protein |
| Cmax | maximum plasma concentration |
| CoQ10 | coenzyme Q10 or ubiquinol |
| COVID-19 | coronavirus disease 2019 |
| CoVs | coronaviruses |
| COX-2 | cyclo-oxygenase-2 |
| CRP | C reactive protein |
| DDAH | dimethylarginine dimethylaminohydrolase |
| D-dimer | dimerized plasma fragment D |
| DHLA | acid dihydrolipoic |
| DNA | deoxyribonucleic acid |
| E | envelope protein |
| e− | electron |
| eNOS | endothelial nitric oxide synthase |
| Fe2+ | ferrous ion |
| FMD | flow-mediated dilation |
| G6PD | glucose-6-phosphate dehydrogenase |
| GDF15 | growth/differentiation factor 15 |
| GPx | glutathione peroxidise |
| GSH | reduced glutathione |
| GSSG | oxidized glutathione |
| H | hydrogen |
| H+ | proton |
| H2O | water |
| H2O2 | hydrogen peroxide |
| HCoV | human coronavirus |
| HLH | hemophagocytic lymphohistiocytosis |
| HO• | hydroxyl radical |
| HOMA-IR | Homeostasis Model Assessment of Insulin Resistance |
| HSV-1 | herpes simplex virus type 1 |
| I | complex I of the mitochondrial respiratory chain |
| i.v. | intravenous administration |
| ICAM-1 | intercellular adhesion molecule-1 |
| IFN-I | type I interferon |
| IFNs | interferons |
| IFN-γ | interferon-γ |
| II | complex II of the mitochondrial respiratory chain |
| III | complex III of the mitochondrial respiratory chain |
| IL | interleukin |
| IL-1 | interleukine-1 |
| IL-1β | interleukin-1β |
| IL-6 | interleukine-6 |
| iNOS | inducible nitric oxide synthase |
| IV | complex IV of the mitochondrial respiratory chain |
| KGDH | α-ketoglutarate dehydrogenase |
| LPS | lipopolysaccharides |
| M | membrane protein |
| MAS | macrophage activation syndrome |
| MasR | mitochondrial assembly receptor |
| MCP-1 | monocyte chemoattractant protein-1 |
| MDA | malondialdehyde |
| MERS-CoV | Middle East respiratory syndrome coronavirus |
| mtROS | mitochondrial ROS |
| N | nucleocapsid protein |
| NAC | N-acetyl cysteine |
| NAD(P) | nicotinamide adenine dinucleotide (phosphate) |
| NAD(P)H | reduced form of nicotinamide adenine dinucleotide (phosphate) |
| NAPQI | N-acetyl-para-benzoquinone imine |
| NETs | neutrophil extracellular traps |
| NF-κB | nuclear factor kappa B |
| NIS-LL | Neuropathy Impairment Score of the lower limbs |
| NO | nitric oxide |
| NOx | NADPH oxidase |
| NRF2 | nuclear factor erythroid 2-related factor 2 |
| NRF2-ARE | nuclear factor erythroid 2-related factor 2–antioxidant response element |
| NSPs | nonstructural proteins |
| O2 | oxygen |
| O2•− | anion superoxide |
| ONOO− | peroxynitrite anion |
| OS | oxidative stress |
| PAI-1 | plasminogen activator inhibitor-1 |
| Pi | inorganic phosphate |
| RAS | renin angiotensin system |
| RBD | receptor-binding domain |
| RNA | ribonucleic acid |
| ROOH | hydroperoxide |
| ROS | reactive oxygen species |
| S | spike protein |
| SARS-CoV | respiratory syndrome coronavirus |
| SARS-CoV-2 | severe acute respiratory syndrome coronavirus 2 |
| SOCS | suppressor of the cytokine signaling proteins |
| SOD | superoxide dismutase |
| TMPRSS2 | transmembrane protease serine 2 |
| TNF-α | tumor necrosis factor-α |
| TSS | Total Symptom Score |
| VCAM-1 | vascular cell adhesion molecule-1 |
| VWF | Von Willebrand Factor |